# Takeda Pharmaceutical Co Ltd (TAK)

Source page: https://stoqly.net/companies/tak

- **Ticker:** TAK (NYSE)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001395064
- **Latest annual report:** 20-F filed 2026-06-17 (https://www.sec.gov/Archives/edgar/data/1395064/000139506426000177/tak-20260331.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $20.91 on 2026-10-30
- **Market cap:** $65.9B
- **EPS, trailing 12 months:** −$0.32
- **Revenue (FY2026):** $29.9B
- **Revenue growth:** −0.5%
- **Revenue growth, 5-year CAGR:** −0.2%
- **Gross margin:** 65.1%
- **Operating margin:** 0.1%
- **Net margin:** −3.4%
- **Free cash flow:** $5.7B
- **Free cash flow margin:** 19.2%
- **Return on invested capital:** 0.0%
- **Return on equity:** −2.2%
- **Net debt:** $26.9B
- **Net debt / EBITDA:** 5.6x
- **Change in share count:** −1.9%
- **Piotroski F-score:** 5/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/tak/figures.csv

| US$ millions | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 15,984 | 15,970 | 18,910 | 30,277 | 30,163 | 31,769 | 29,731 | 29,501 | 30,053 | 29,890 |
| Operating income | 1,438 | 2,181 | 2,143 | 924 | 4,804 | 4,102 | 3,621 | 1,481 | 2,247 | 41 |
| Net income | 1,061 | 1,686 | 1,219 | 407 | 3,547 | 2,048 | 2,340 | 997 | 708 | -1,011 |
| Diluted EPS (US$) | 0.67 | 1.07 | 0.63 | 0.13 | 1.13 | 0.65 | 0.75 | 0.32 | 0.22 | -0.32 |
| Operating cash flow | 2,412 | 3,408 | 2,962 | 6,161 | 9,536 | 9,997 | 7,213 | 4,956 | 6,935 | 6,909 |
| Free cash flow | 1,843 | 2,804 | 2,261 | 4,992 | 8,487 | 8,900 | 6,175 | 3,743 | 5,618 | 5,741 |
| Cash | 2,857 | 2,767 | 6,338 | 5,875 | 8,721 | 6,978 | 4,006 | 3,028 | 2,577 | 3,731 |
| Debt and leases | — | 9,260 | 51,918 | 46,932 | 41,836 | 35,687 | 32,906 | 32,038 | 30,218 | 30,608 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.